News
CRITICARE, February 15-19, Pune, India
January 24 2012
Conference on Continuous Renal Replacement Therapies (CRRT), February 12-15, San Diego, USA
January 24 2012
MEDLAB, Arab Health, January 23-26, Dubai, UAE
January 16 2012
An addition to the Obesity and Type 2 Diabetes antibody portfolio
December 22 2011
Better kidney markers ahead?
December 05 2011
New NGAL.com website launched
November 24 2011
MEDICA, November 16-19, Düsseldorf, Germany
October 26 2011
ASN Kidney Week, November 8-13, Pennsylvania, Philadelphia, USA
October 20 2011
ESICM 2011, October 1-5, Berlin, Germany
September 06 2011
AACC Clinical Lab Expo, July 24-28, Atlanta
July 04 2011
CRITICARE 2010, February 10-14, Hyderabad, India
January 25 2010 by Ana Belén Enfedaque Buisán
BioPorto Diagnostics will be exhibiting at the upcoming International Critical Care Congress of the Indian Society of Critical Care Medicine (ISCCM). The exhibition will be a joint venture with CPC Diagnostics, BioPorto’s exclusive distributor in South and West India.
Aimed at strengthing the existing bond between industry and the physician community and exploring means to provide affordable medical care to deserving patients, CRITICARE 2010 is one of the most important events on the calendar of every critical care practitioner in India. Around 3,000 Intensivists, Physicians, Pulmonologist, Paediatricians and Anaesthesiologist delegates from India and neighboring countries are expected to take part in this congress.
At the congress, BioPorto Diagnostics will promote their proprietary biomarkers - NGAL for AKI diagnosis and APC-PCI for sepsis.
Trine Østerbye, Sales and Marketing Manager toe@bioporto.com and Ishan Gupta, Business Development Manager, Sales ig@bioporto.com will represent BioPorto Diagnostics. Visit us at booth 34-35 in the Hyderabad International Convention Center.
For further information on CRITICARE 2010: http://criticare2010.org/
